Bristol-Myers Squibb
BMY
BMY
2,363 hedge funds and large institutions have $108B invested in Bristol-Myers Squibb in 2021 Q2 according to their latest regulatory filings, with 146 funds opening new positions, 959 increasing their positions, 953 reducing their positions, and 112 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1% more repeat investments, than reductions
Existing positions increased: 959 | Existing positions reduced: 953
0.21% more ownership
Funds ownership: 72.9% → 73.11% (+0.21%)
0% more funds holding
Funds holding: 2,362 → 2,363 (+1)
Holders
2,363
Holding in Top 10
72
Calls
$1.47B
Puts
$1.06B
Top Buyers
| 1 | +$596M | |
| 2 | +$485M | |
| 3 | +$409M | |
| 4 |
IFP
Independent Franchise Partners
London,
United Kingdom
|
+$219M |
| 5 |
Two Sigma Investments
New York
|
+$206M |
Top Sellers
| 1 | -$455M | |
| 2 | -$317M | |
| 3 | -$300M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$243M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$228M |